世界の胆道障害治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Biliary Tract Disorder Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5617
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、107ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、胆道障害治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（医薬品、手術、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・胆道障害治療の市場動向
・企業の競争状況、市場シェア
・胆道障害治療の種類別市場規模と予測2016-2027（医薬品、手術、その他）
・胆道障害治療の用途別市場規模と予測2016-2027（病院、診療所、その他）
・胆道障害治療の北米市場規模2016-2027（アメリカ、カナダ）
・胆道障害治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・胆道障害治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・胆道障害治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・胆道障害治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（AstraZeneca、Asklepion Pharmaceuticals、Intuitive Surgical、Merck、Abbott Laboratories、Boston Scientific、Conmed、Cook Medical、B. Braun Melsungen、Medtronic、Terumo、Merit Medical、Olympus、Becton Dickinson）
・結論

Biliary Tract Disorder Treatment is treatments that used to treat biliary diseases. Biliary disease refers to diseases affecting the bile ducts, gallbladder and other structures involved in the production and transportation of bile.

Market Analysis and Insights: Global Biliary Tract Disorder Treatment Market
The global Biliary Tract Disorder Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biliary Tract Disorder Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biliary Tract Disorder Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biliary Tract Disorder Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biliary Tract Disorder Treatment market.

Global Biliary Tract Disorder Treatment Scope and Market Size
Biliary Tract Disorder Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biliary Tract Disorder Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Mecine
Surgery
Other

Segment by Application
Hospitals
Clinics
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AstraZeneca
Asklepion Pharmaceuticals
Intuitive Surgical
Merck
Abbott Laboratories
Boston Scientific
Conmed
Cook Medical
B. Braun Melsungen
Medtronic
Terumo
Merit Medical
Olympus
Becton Dickinson

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biliary Tract Disorder Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Mecine
1.2.3 Surgery
1.2.4 Other
1.3 Market by Application
1.3.1 Global Biliary Tract Disorder Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Biliary Tract Disorder Treatment Market Perspective (2016-2027)
2.2 Biliary Tract Disorder Treatment Growth Trends by Regions
2.2.1 Biliary Tract Disorder Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Biliary Tract Disorder Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Biliary Tract Disorder Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Biliary Tract Disorder Treatment Industry Dynamic
2.3.1 Biliary Tract Disorder Treatment Market Trends
2.3.2 Biliary Tract Disorder Treatment Market Drivers
2.3.3 Biliary Tract Disorder Treatment Market Challenges
2.3.4 Biliary Tract Disorder Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Biliary Tract Disorder Treatment Players by Revenue
3.1.1 Global Top Biliary Tract Disorder Treatment Players by Revenue (2016-2021)
3.1.2 Global Biliary Tract Disorder Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Biliary Tract Disorder Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Biliary Tract Disorder Treatment Revenue
3.4 Global Biliary Tract Disorder Treatment Market Concentration Ratio
3.4.1 Global Biliary Tract Disorder Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biliary Tract Disorder Treatment Revenue in 2020
3.5 Biliary Tract Disorder Treatment Key Players Head office and Area Served
3.6 Key Players Biliary Tract Disorder Treatment Product Solution and Service
3.7 Date of Enter into Biliary Tract Disorder Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Biliary Tract Disorder Treatment Breakdown Data by Type
4.1 Global Biliary Tract Disorder Treatment Historic Market Size by Type (2016-2021)
4.2 Global Biliary Tract Disorder Treatment Forecasted Market Size by Type (2022-2027)

5 Biliary Tract Disorder Treatment Breakdown Data by Application
5.1 Global Biliary Tract Disorder Treatment Historic Market Size by Application (2016-2021)
5.2 Global Biliary Tract Disorder Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Biliary Tract Disorder Treatment Market Size (2016-2027)
6.2 North America Biliary Tract Disorder Treatment Market Size by Type
6.2.1 North America Biliary Tract Disorder Treatment Market Size by Type (2016-2021)
6.2.2 North America Biliary Tract Disorder Treatment Market Size by Type (2022-2027)
6.2.3 North America Biliary Tract Disorder Treatment Market Size by Type (2016-2027)
6.3 North America Biliary Tract Disorder Treatment Market Size by Application
6.3.1 North America Biliary Tract Disorder Treatment Market Size by Application (2016-2021)
6.3.2 North America Biliary Tract Disorder Treatment Market Size by Application (2022-2027)
6.3.3 North America Biliary Tract Disorder Treatment Market Size by Application (2016-2027)
6.4 North America Biliary Tract Disorder Treatment Market Size by Country
6.4.1 North America Biliary Tract Disorder Treatment Market Size by Country (2016-2021)
6.4.2 North America Biliary Tract Disorder Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Biliary Tract Disorder Treatment Market Size (2016-2027)
7.2 Europe Biliary Tract Disorder Treatment Market Size by Type
7.2.1 Europe Biliary Tract Disorder Treatment Market Size by Type (2016-2021)
7.2.2 Europe Biliary Tract Disorder Treatment Market Size by Type (2022-2027)
7.2.3 Europe Biliary Tract Disorder Treatment Market Size by Type (2016-2027)
7.3 Europe Biliary Tract Disorder Treatment Market Size by Application
7.3.1 Europe Biliary Tract Disorder Treatment Market Size by Application (2016-2021)
7.3.2 Europe Biliary Tract Disorder Treatment Market Size by Application (2022-2027)
7.3.3 Europe Biliary Tract Disorder Treatment Market Size by Application (2016-2027)
7.4 Europe Biliary Tract Disorder Treatment Market Size by Country
7.4.1 Europe Biliary Tract Disorder Treatment Market Size by Country (2016-2021)
7.4.2 Europe Biliary Tract Disorder Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Biliary Tract Disorder Treatment Market Size (2016-2027)
8.2 Asia-Pacific Biliary Tract Disorder Treatment Market Size by Type
8.2.1 Asia-Pacific Biliary Tract Disorder Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Biliary Tract Disorder Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Biliary Tract Disorder Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Biliary Tract Disorder Treatment Market Size by Application
8.3.1 Asia-Pacific Biliary Tract Disorder Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Biliary Tract Disorder Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Biliary Tract Disorder Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Biliary Tract Disorder Treatment Market Size by Region
8.4.1 Asia-Pacific Biliary Tract Disorder Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Biliary Tract Disorder Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Biliary Tract Disorder Treatment Market Size (2016-2027)
9.2 Latin America Biliary Tract Disorder Treatment Market Size by Type
9.2.1 Latin America Biliary Tract Disorder Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Biliary Tract Disorder Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Biliary Tract Disorder Treatment Market Size by Type (2016-2027)
9.3 Latin America Biliary Tract Disorder Treatment Market Size by Application
9.3.1 Latin America Biliary Tract Disorder Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Biliary Tract Disorder Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Biliary Tract Disorder Treatment Market Size by Application (2016-2027)
9.4 Latin America Biliary Tract Disorder Treatment Market Size by Country
9.4.1 Latin America Biliary Tract Disorder Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Biliary Tract Disorder Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Biliary Tract Disorder Treatment Market Size (2016-2027)
10.2 Middle East & Africa Biliary Tract Disorder Treatment Market Size by Type
10.2.1 Middle East & Africa Biliary Tract Disorder Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Biliary Tract Disorder Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Biliary Tract Disorder Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Biliary Tract Disorder Treatment Market Size by Application
10.3.1 Middle East & Africa Biliary Tract Disorder Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Biliary Tract Disorder Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Biliary Tract Disorder Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Biliary Tract Disorder Treatment Market Size by Country
10.4.1 Middle East & Africa Biliary Tract Disorder Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Biliary Tract Disorder Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Biliary Tract Disorder Treatment Introduction
11.1.4 AstraZeneca Revenue in Biliary Tract Disorder Treatment Business (2016-2021)
11.1.5 AstraZeneca Recent Development
11.2 Asklepion Pharmaceuticals
11.2.1 Asklepion Pharmaceuticals Company Details
11.2.2 Asklepion Pharmaceuticals Business Overview
11.2.3 Asklepion Pharmaceuticals Biliary Tract Disorder Treatment Introduction
11.2.4 Asklepion Pharmaceuticals Revenue in Biliary Tract Disorder Treatment Business (2016-2021)
11.2.5 Asklepion Pharmaceuticals Recent Development
11.3 Intuitive Surgical
11.3.1 Intuitive Surgical Company Details
11.3.2 Intuitive Surgical Business Overview
11.3.3 Intuitive Surgical Biliary Tract Disorder Treatment Introduction
11.3.4 Intuitive Surgical Revenue in Biliary Tract Disorder Treatment Business (2016-2021)
11.3.5 Intuitive Surgical Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Biliary Tract Disorder Treatment Introduction
11.4.4 Merck Revenue in Biliary Tract Disorder Treatment Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Abbott Laboratories
11.5.1 Abbott Laboratories Company Details
11.5.2 Abbott Laboratories Business Overview
11.5.3 Abbott Laboratories Biliary Tract Disorder Treatment Introduction
11.5.4 Abbott Laboratories Revenue in Biliary Tract Disorder Treatment Business (2016-2021)
11.5.5 Abbott Laboratories Recent Development
11.6 Boston Scientific
11.6.1 Boston Scientific Company Details
11.6.2 Boston Scientific Business Overview
11.6.3 Boston Scientific Biliary Tract Disorder Treatment Introduction
11.6.4 Boston Scientific Revenue in Biliary Tract Disorder Treatment Business (2016-2021)
11.6.5 Boston Scientific Recent Development
11.7 Conmed
11.7.1 Conmed Company Details
11.7.2 Conmed Business Overview
11.7.3 Conmed Biliary Tract Disorder Treatment Introduction
11.7.4 Conmed Revenue in Biliary Tract Disorder Treatment Business (2016-2021)
11.7.5 Conmed Recent Development
11.8 Cook Medical
11.8.1 Cook Medical Company Details
11.8.2 Cook Medical Business Overview
11.8.3 Cook Medical Biliary Tract Disorder Treatment Introduction
11.8.4 Cook Medical Revenue in Biliary Tract Disorder Treatment Business (2016-2021)
11.8.5 Cook Medical Recent Development
11.9 B. Braun Melsungen
11.9.1 B. Braun Melsungen Company Details
11.9.2 B. Braun Melsungen Business Overview
11.9.3 B. Braun Melsungen Biliary Tract Disorder Treatment Introduction
11.9.4 B. Braun Melsungen Revenue in Biliary Tract Disorder Treatment Business (2016-2021)
11.9.5 B. Braun Melsungen Recent Development
11.10 Medtronic
11.10.1 Medtronic Company Details
11.10.2 Medtronic Business Overview
11.10.3 Medtronic Biliary Tract Disorder Treatment Introduction
11.10.4 Medtronic Revenue in Biliary Tract Disorder Treatment Business (2016-2021)
11.10.5 Medtronic Recent Development
11.11 Terumo
11.11.1 Terumo Company Details
11.11.2 Terumo Business Overview
11.11.3 Terumo Biliary Tract Disorder Treatment Introduction
11.11.4 Terumo Revenue in Biliary Tract Disorder Treatment Business (2016-2021)
11.11.5 Terumo Recent Development
11.12 Merit Medical
11.12.1 Merit Medical Company Details
11.12.2 Merit Medical Business Overview
11.12.3 Merit Medical Biliary Tract Disorder Treatment Introduction
11.12.4 Merit Medical Revenue in Biliary Tract Disorder Treatment Business (2016-2021)
11.12.5 Merit Medical Recent Development
11.13 Olympus
11.13.1 Olympus Company Details
11.13.2 Olympus Business Overview
11.13.3 Olympus Biliary Tract Disorder Treatment Introduction
11.13.4 Olympus Revenue in Biliary Tract Disorder Treatment Business (2016-2021)
11.13.5 Olympus Recent Development
11.14 Becton Dickinson
11.14.1 Becton Dickinson Company Details
11.14.2 Becton Dickinson Business Overview
11.14.3 Becton Dickinson Biliary Tract Disorder Treatment Introduction
11.14.4 Becton Dickinson Revenue in Biliary Tract Disorder Treatment Business (2016-2021)
11.14.5 Becton Dickinson Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Biliary Tract Disorder Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Mecine
Table 3. Key Players of Surgery
Table 4. Key Players of Other
Table 5. Global Biliary Tract Disorder Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Biliary Tract Disorder Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Biliary Tract Disorder Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Biliary Tract Disorder Treatment Market Share by Regions (2016-2021)
Table 9. Global Biliary Tract Disorder Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Biliary Tract Disorder Treatment Market Share by Regions (2022-2027)
Table 11. Biliary Tract Disorder Treatment Market Trends
Table 12. Biliary Tract Disorder Treatment Market Drivers
Table 13. Biliary Tract Disorder Treatment Market Challenges
Table 14. Biliary Tract Disorder Treatment Market Restraints
Table 15. Global Biliary Tract Disorder Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Biliary Tract Disorder Treatment Market Share by Players (2016-2021)
Table 17. Global Top Biliary Tract Disorder Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biliary Tract Disorder Treatment as of 2020)
Table 18. Ranking of Global Top Biliary Tract Disorder Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Biliary Tract Disorder Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Biliary Tract Disorder Treatment Product Solution and Service
Table 22. Date of Enter into Biliary Tract Disorder Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Biliary Tract Disorder Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Biliary Tract Disorder Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Biliary Tract Disorder Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Biliary Tract Disorder Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Biliary Tract Disorder Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Biliary Tract Disorder Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Biliary Tract Disorder Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Biliary Tract Disorder Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Biliary Tract Disorder Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Biliary Tract Disorder Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Biliary Tract Disorder Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Biliary Tract Disorder Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Biliary Tract Disorder Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Biliary Tract Disorder Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Biliary Tract Disorder Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Biliary Tract Disorder Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Biliary Tract Disorder Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Biliary Tract Disorder Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Biliary Tract Disorder Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Biliary Tract Disorder Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Biliary Tract Disorder Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Biliary Tract Disorder Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Biliary Tract Disorder Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Biliary Tract Disorder Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Biliary Tract Disorder Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Biliary Tract Disorder Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Biliary Tract Disorder Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Biliary Tract Disorder Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Biliary Tract Disorder Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Biliary Tract Disorder Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Biliary Tract Disorder Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Biliary Tract Disorder Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Biliary Tract Disorder Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Biliary Tract Disorder Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Biliary Tract Disorder Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Biliary Tract Disorder Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Biliary Tract Disorder Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Biliary Tract Disorder Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. AstraZeneca Company Details
Table 63. AstraZeneca Business Overview
Table 64. AstraZeneca Biliary Tract Disorder Treatment Product
Table 65. AstraZeneca Revenue in Biliary Tract Disorder Treatment Business (2016-2021) & (US$ Million)
Table 66. AstraZeneca Recent Development
Table 67. Asklepion Pharmaceuticals Company Details
Table 68. Asklepion Pharmaceuticals Business Overview
Table 69. Asklepion Pharmaceuticals Biliary Tract Disorder Treatment Product
Table 70. Asklepion Pharmaceuticals Revenue in Biliary Tract Disorder Treatment Business (2016-2021) & (US$ Million)
Table 71. Asklepion Pharmaceuticals Recent Development
Table 72. Intuitive Surgical Company Details
Table 73. Intuitive Surgical Business Overview
Table 74. Intuitive Surgical Biliary Tract Disorder Treatment Product
Table 75. Intuitive Surgical Revenue in Biliary Tract Disorder Treatment Business (2016-2021) & (US$ Million)
Table 76. Intuitive Surgical Recent Development
Table 77. Merck Company Details
Table 78. Merck Business Overview
Table 79. Merck Biliary Tract Disorder Treatment Product
Table 80. Merck Revenue in Biliary Tract Disorder Treatment Business (2016-2021) & (US$ Million)
Table 81. Merck Recent Development
Table 82. Abbott Laboratories Company Details
Table 83. Abbott Laboratories Business Overview
Table 84. Abbott Laboratories Biliary Tract Disorder Treatment Product
Table 85. Abbott Laboratories Revenue in Biliary Tract Disorder Treatment Business (2016-2021) & (US$ Million)
Table 86. Abbott Laboratories Recent Development
Table 87. Boston Scientific Company Details
Table 88. Boston Scientific Business Overview
Table 89. Boston Scientific Biliary Tract Disorder Treatment Product
Table 90. Boston Scientific Revenue in Biliary Tract Disorder Treatment Business (2016-2021) & (US$ Million)
Table 91. Boston Scientific Recent Development
Table 92. Conmed Company Details
Table 93. Conmed Business Overview
Table 94. Conmed Biliary Tract Disorder Treatment Product
Table 95. Conmed Revenue in Biliary Tract Disorder Treatment Business (2016-2021) & (US$ Million)
Table 96. Conmed Recent Development
Table 97. Cook Medical Company Details
Table 98. Cook Medical Business Overview
Table 99. Cook Medical Revenue in Biliary Tract Disorder Treatment Business (2016-2021) & (US$ Million)
Table 100. Cook Medical Recent Development
Table 101. B. Braun Melsungen Company Details
Table 102. B. Braun Melsungen Business Overview
Table 103. B. Braun Melsungen Biliary Tract Disorder Treatment Product
Table 104. B. Braun Melsungen Revenue in Biliary Tract Disorder Treatment Business (2016-2021) & (US$ Million)
Table 105. B. Braun Melsungen Recent Development
Table 106. Medtronic Company Details
Table 107. Medtronic Business Overview
Table 108. Medtronic Biliary Tract Disorder Treatment Product
Table 109. Medtronic Revenue in Biliary Tract Disorder Treatment Business (2016-2021) & (US$ Million)
Table 110. Medtronic Recent Development
Table 111. Terumo Company Details
Table 112. Terumo Business Overview
Table 113. Terumo Biliary Tract Disorder Treatment Product
Table 114. Terumo Revenue in Biliary Tract Disorder Treatment Business (2016-2021) & (US$ Million)
Table 115. Terumo Recent Development
Table 116. Merit Medical Company Details
Table 117. Merit Medical Business Overview
Table 118. Merit Medical Biliary Tract Disorder Treatment Product
Table 119. Merit Medical Revenue in Biliary Tract Disorder Treatment Business (2016-2021) & (US$ Million)
Table 120. Merit Medical Recent Development
Table 121. Olympus Company Details
Table 122. Olympus Business Overview
Table 123. Olympus Biliary Tract Disorder Treatment Product
Table 124. Olympus Revenue in Biliary Tract Disorder Treatment Business (2016-2021) & (US$ Million)
Table 125. Olympus Recent Development
Table 126. Becton Dickinson Company Details
Table 127. Becton Dickinson Business Overview
Table 128. Becton Dickinson Biliary Tract Disorder Treatment Product
Table 129. Becton Dickinson Revenue in Biliary Tract Disorder Treatment Business (2016-2021) & (US$ Million)
Table 130. Becton Dickinson Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biliary Tract Disorder Treatment Market Share by Type: 2020 VS 2027
Figure 2. Mecine Features
Figure 3. Surgery Features
Figure 4. Other Features
Figure 5. Global Biliary Tract Disorder Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Other Case Studies
Figure 9. Biliary Tract Disorder Treatment Report Years Considered
Figure 10. Global Biliary Tract Disorder Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Biliary Tract Disorder Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Biliary Tract Disorder Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Biliary Tract Disorder Treatment Market Share by Regions (2022-2027)
Figure 14. Global Biliary Tract Disorder Treatment Market Share by Players in 2020
Figure 15. Global Top Biliary Tract Disorder Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biliary Tract Disorder Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Biliary Tract Disorder Treatment Revenue in 2020
Figure 17. Global Biliary Tract Disorder Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Biliary Tract Disorder Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Biliary Tract Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Biliary Tract Disorder Treatment Market Share by Type (2016-2027)
Figure 21. North America Biliary Tract Disorder Treatment Market Share by Application (2016-2027)
Figure 22. North America Biliary Tract Disorder Treatment Market Share by Country (2016-2027)
Figure 23. United States Biliary Tract Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Biliary Tract Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Biliary Tract Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Biliary Tract Disorder Treatment Market Share by Type (2016-2027)
Figure 27. Europe Biliary Tract Disorder Treatment Market Share by Application (2016-2027)
Figure 28. Europe Biliary Tract Disorder Treatment Market Share by Country (2016-2027)
Figure 29. Germany Biliary Tract Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Biliary Tract Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Biliary Tract Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Biliary Tract Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Biliary Tract Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Biliary Tract Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Biliary Tract Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Biliary Tract Disorder Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Biliary Tract Disorder Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Biliary Tract Disorder Treatment Market Share by Region (2016-2027)
Figure 39. China Biliary Tract Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Biliary Tract Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Biliary Tract Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Biliary Tract Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Biliary Tract Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Biliary Tract Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Biliary Tract Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Biliary Tract Disorder Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Biliary Tract Disorder Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Biliary Tract Disorder Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Biliary Tract Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Biliary Tract Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Biliary Tract Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Biliary Tract Disorder Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Biliary Tract Disorder Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Biliary Tract Disorder Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Biliary Tract Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Biliary Tract Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Biliary Tract Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. AstraZeneca Revenue Growth Rate in Biliary Tract Disorder Treatment Business (2016-2021)
Figure 59. Asklepion Pharmaceuticals Revenue Growth Rate in Biliary Tract Disorder Treatment Business (2016-2021)
Figure 60. Intuitive Surgical Revenue Growth Rate in Biliary Tract Disorder Treatment Business (2016-2021)
Figure 61. Merck Revenue Growth Rate in Biliary Tract Disorder Treatment Business (2016-2021)
Figure 62. Abbott Laboratories Revenue Growth Rate in Biliary Tract Disorder Treatment Business (2016-2021)
Figure 63. Boston Scientific Revenue Growth Rate in Biliary Tract Disorder Treatment Business (2016-2021)
Figure 64. Conmed Revenue Growth Rate in Biliary Tract Disorder Treatment Business (2016-2021)
Figure 65. Cook Medical Revenue Growth Rate in Biliary Tract Disorder Treatment Business (2016-2021)
Figure 66. B. Braun Melsungen Revenue Growth Rate in Biliary Tract Disorder Treatment Business (2016-2021)
Figure 67. Medtronic Revenue Growth Rate in Biliary Tract Disorder Treatment Business (2016-2021)
Figure 68. Terumo Revenue Growth Rate in Biliary Tract Disorder Treatment Business (2016-2021)
Figure 69. Merit Medical Revenue Growth Rate in Biliary Tract Disorder Treatment Business (2016-2021)
Figure 70. Olympus Revenue Growth Rate in Biliary Tract Disorder Treatment Business (2016-2021)
Figure 71. Becton Dickinson Revenue Growth Rate in Biliary Tract Disorder Treatment Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

以下、関連資料のご紹介

世界の胆道閉鎖症治療市場規模・現状・予測（2021年-2027年）

Global Biliary Atresia Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3899 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、胆道閉鎖症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、手術治療）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、...

世界の上気道感染症治療市場規模・現状・予測（2021年-2027年）

Global Upper Respiratory Tract Infection Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6058 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、上気道感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、非ステロイド性抗炎症薬 (NSAIDs) ＆鼻充血除去薬、その他）、用途別市場規模（鼻炎、副鼻腔炎、鼻咽頭炎、喉頭蓋炎、喉頭炎...

世界の物質使用障害治療市場規模・現状・予測（2021年-2027年）

Global Substance Use Disorder Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4914 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、物質使用障害治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アルコール乱用治療、ニコチン乱用治療、薬物乱用治療）、用途別市場規模（病院、クリニック、在宅医療設備）、主要地域別市場規模（北米、アメリ...

世界の気道感染症（RTI）治療市場規模・現状・予測（2021年-2027年）

Global Respiratory Tract infections (RTIs) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4818 2021年6月 115Pages
QYResearch社発行の本調査レポートでは、気道感染症（RTI）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カプセル、錠剤）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界の網膜障害治療市場規模・現状・予測（2021年-2027年）

Global Retinal Disorder Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4826 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、網膜障害治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ジェル、カプセル＆錠剤、点眼薬、軟膏）、用途別市場規模（病院薬局、オンライン薬局、小売薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジ...

世界の性欲低下障害（HSDD）治療市場規模・現状・予測（2021年-2027年）

Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4340 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、性欲低下障害（HSDD）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ブスピロン、ブプロピオン、テストステロン、フリバンセリン、ブレメラノチド、認知行動療法）、用途別市場規模（病院、診療所、その...

世界の心的外傷後ストレス障害治療市場規模・現状・予測（2021年-2027年）

Global Post-Traumatic Stress Disorder Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4739 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、心的外傷後ストレス障害治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗うつ薬、抗不安薬、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日...

世界の破壊的行動障害（DBD）治療市場規模・現状・予測（2021年-2027年）

Global Disruptive Behavior Disorder (DBD) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4142 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、破壊的行動障害（DBD）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物療法、心理療法）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、...

世界のピカ摂食障害治療市場規模・現状・予測（2021年-2027年）

Global Pica Eating Disorder Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5304 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、ピカ摂食障害治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（栄養補助食品、抗精神病薬、抗うつ薬、気分安定薬）、用途別市場規模（病院薬局、小売薬局、ドラッグストア、通信販売薬局）、主要地域別市場規模...

世界の胆管腫瘍市場規模・現状・予測（2021年-2027年）

Global Biliary Tumor Market Size, Status and Forecast 2021-2027
QFJ1-5618 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、胆管腫瘍の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（医薬品、手術、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界の胆道閉鎖症治療市場規模・現状・予測（2021年-2027年） Biliary atresia or extra hepatic ductopenia is an acquired disease of the liver. This disease is characterized by the obliteration of the extra hepatic biliary system which results in obstruction of the bile flow from the liver to gall bladder. Market Analysis and Insights: Global Biliary Atresia Tr…
世界の上気道感染症治療市場規模・現状・予測（2021年-2027年） Rhinitis, sinusitis, nasopharyngitis, epiglottitis, laryngitis, and whooping cough are some of the types of upper respiratory tract infections. It can be treated with various drugs such as azithromycin, doxycycline, xylometazoline, propylhexedrine, amoxicillin, clarithromycin, aspirin, ibuprofen, er…
胆道閉鎖症治療のグローバル市場：規模・現状・予測2019-2025 Biliary atresia or extra hepatic ductopenia is an acquired disease of the liver. This disease is characterized by the obliteration of the extra hepatic biliary system which results in obstruction of the bile flow from the liver to gall bladder.In 2018, the global Biliary Atresia Treatment market siz…
胆道閉鎖症治療のグローバル市場：規模・現状・予測2019-2025 Biliary atresia or extra hepatic ductopenia is an acquired disease of the liver. This disease is characterized by the obliteration of the extra hepatic biliary system which results in obstruction of the bile flow from the liver to gall bladder.In 2018, the global Biliary Atresia Treatment market siz…
世界の物質使用障害治療市場規模・現状・予測（2021年-2027年） Drug addiction, also called substance use disorder, is a disease that affects a person's brain and behavior and leads to an inability to control the use of a legal or illegal drug or medication. Substances such as alcohol, marijuana and nicotine also are considered drugs. Market Analysis and Insight…